Glycemic control and hypoglycemia in Asian type 2 diabetes patients treated with insulin glargine plus glimepiride versus NPH insulin plus glimepiride

被引：0

|

作者：

Pan, CY

Bianchi-Biscay, M

Chung, KD

Kim, KW

机构：

来源：

DIABETES | 2004年 / 53卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：A488 / A488

页数：1

相关论文

共 50 条

[31] Glimepiride combined with morning insulin glargine, bedtime neutral protamine Hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes -: A randomized, controlled trial
Fritsche, A
Schweitzer, MA
Häring, HU
[J]. ANNALS OF INTERNAL MEDICINE, 2003, 138 (12) : 952 - 959
[32] Improvement in overall blood glucose control with insulin glargine plus insulin lispro in comparison with NPH insulin plus unmodified human insulin in people with Type 1 diabetes.
Ashwell, S
Amiel, S
Bilous, R
Heller, S
Hepburn, D
Home, P
[J]. DIABETOLOGIA, 2003, 46 : A271 - A271
[33] Duration of Diabetes and Hypoglycemia Rates in T2D Patients Treated with Insulin Glargine vs NPH Insulin
Dailey, George
Aurand, Lisa A.
Garg, Satish K.
[J]. DIABETES, 2011, 60 : A602 - A602
[34] NPH Insulin Versus Insulin Glargine Versus NPH Insulin Plus Insulin Glargine for the Treatment of Dexamethasone-Induced Hyperglycemia in Patients With COVID-19: A Retrospective Cohort Study
Fornwald, Courtney R. R.
Tuttle, Natalie S. S.
Murphy, Julie A. A.
[J]. JOURNAL OF PHARMACY TECHNOLOGY, 2023, 39 (02) : 68 - 74
[35] Less symptomatic hypoglycemia with insulin glargine compared to NPH in patients with type 2 diabetes.
Fonseca, V
Bell, D
Mecca, T
[J]. DIABETOLOGIA, 2001, 44 : A207 - A207
[36] Real-world characteristics of patients with type 2 diabetes initiating insulin glargine plus exenatide or insulin glargine plus liraglutide
Di Genio, A.
Ling, Z.
Davis, K. L.
Meyers, J. L.
Dalal, M. R.
[J]. DIABETOLOGIA, 2012, 55 : S328 - S328
[37] Treatment satisfaction and quality of life with insulin glargine plus insulin lispro compared with NPH insulin plus unmodified human insulin in individuals with type 1 diabetes
Ashwell, Simon G.
Bradley, Clare
Stephens, James W.
Witthaus, Elke
Home, Philip D.
[J]. DIABETES CARE, 2008, 31 (06) : 1112 - 1117
[38] Economic impact of nocturnal hypoglycemia associated with the treatment of type 2 diabetes with insulin glargine or NPH insulin
Rubio-Terres, Carlos
Alvarez Guisasola, Fernando
Navarro Perez, Jorge
Delgado Alvarez, Elias
Azriel Mira, Sharona
Magana, Ana
[J]. AVANCES EN DIABETOLOGIA, 2013, 29 (01): : 19 - 26
[39] Hypoglycemia and glycemic control in type 1 diabetes: a meta-analysis of five randomized controlled trials comparing NPH insulin with insulin glargine
Mullins, Peter
Jarvinen, Hannele Yki
Sharplin, Peter A.
Riddle, Matthew
[J]. DIABETES, 2007, 56 : A575 - A576
[40] Less symptomatic hypoglycemia with bedtime insulin glargine (Lantus®) compared to bedtime NPH insulin in patients with type 2 diabetes
Fonseca, V
Bell, D
Mecca, T
[J]. DIABETES, 2001, 50 : A112 - A112

← 1 2 3 4 5 →